These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9117079

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Therapy of acute Guillain-Barré syndrome. A national multicenter study].
    Kloss TM, Haupt WF, Philipp T, Diener HC.
    Nervenarzt; 1994 Dec; 65(12):881-3. PubMed ID: 7854512
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Guillain-Barré syndrome.
    Evans OB, Vedanarayanan V.
    Pediatr Rev; 1997 Jan; 18(1):10-6. PubMed ID: 8993064
    [Abstract] [Full Text] [Related]

  • 26. Clinical variants of Guillain-Barre syndrome: some aspects of differential diagnosis.
    Dididze MN.
    Georgian Med News; 2009 Jan; (166):48-51. PubMed ID: 19202218
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Plasmapheresis in 2 children with Guillain-Barré syndrome].
    Rotteveel JJ, Mullaart RA, Weemaes CM, van Empelen R.
    Tijdschr Kindergeneeskd; 1983 Apr; 51(2):57-62. PubMed ID: 6879585
    [Abstract] [Full Text] [Related]

  • 31. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ, Alshubaili AF, Santhamoorthy P, Sharafuddin KM.
    Med Princ Pract; 2008 Apr; 17(5):422-4. PubMed ID: 18685286
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Changing views of Guillain-Barré syndrome.
    Asbury AK, McKhann GM.
    Ann Neurol; 1997 Mar; 41(3):287-8. PubMed ID: 9066348
    [No Abstract] [Full Text] [Related]

  • 35. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M, Weinberger M.
    J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805
    [Abstract] [Full Text] [Related]

  • 36. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome.
    Cochen V, Arnulf I, Demeret S, Neulat ML, Gourlet V, Drouot X, Moutereau S, Derenne JP, Similowski T, Willer JC, Pierrot-Deseiligny C, Bolgert F.
    Brain; 2005 Nov; 128(Pt 11):2535-45. PubMed ID: 16000335
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Pharmacoeconomics of therapy for Guillain-Barré syndrome: plasma exchange and intravenous immunoglobulin.
    Tsai CP, Wang KC, Liu CY, Sheng WY, Lee TC.
    J Clin Neurosci; 2007 Jul; 14(7):625-9. PubMed ID: 17532498
    [Abstract] [Full Text] [Related]

  • 40. Therapeutic strategies in the Guillain-Barré syndrome.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun; 23(2):159-68. PubMed ID: 12894381
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.